AIDS - PMC - NCBI

Luana Rodrigues da Silva, Ellen Thallita Hill Araújo, Moisés Lopes Carvalho, Camila Aparecida Pinheiro Landim Almeida, Adélia Dalva da Silva Oliveira, Patrícia Maria Gomes de Carvalho, Tatyanne Silva Rodrigues, Viriato Campelo

Sao Paulo Med J. 2018; 136(1): 37–43. Published online 2018 Jan 15. doi: 10.1590/1516-3180.2017.0130100917

PMCID:: PMC9924163

Abstract Article PDF–224K

Select item 41929144.

Acquired immunodeficiency syndrome in California's Medicaid program, 1981-84

Roxanne M. Andrews, Margaret A. Keyes, Penelope L. Pine

Health Care Financ Rev. 1988 Fall; 10(1): 95–103.

PMCID:: PMC4192914

Abstract Article PDF–517K

Select item 88908185.

Talaromyces marneffei Mp1p Antigen Detection may Play an Important Role in the Early Diagnosis of Talaromycosis in Patients with Acquired Immunodeficiency Syndrome

Xiaoman Chen, Xu Ou, Haodi Wang, Liya Li, Pengle Guo, Xiejie Chen, Weiping Cai, Xiaoping Tang, Linghua Li

Mycopathologia. 2022; 187(2-3): 205–215. Published online 2022 Mar 3. doi: 10.1007/s11046-022-00618-9

PMCID:: PMC8890818

Abstract Article PDF–647K

Select item 103345476.

Metagenomic next-generation sequencing for rapid detection of pulmonary infection in patients with acquired immunodeficiency syndrome

Juan Zhong, Yanfen Liu, Na Luo, Qiu Wei, Qisi Su, Jun Zou, Xiaozhong Wu, Xianzhen Huang, Yuting Jiang, Lijuan Liang, Hongmian Li, Jianyan Lin

Ann Clin Microbiol Antimicrob. 2023; 22: 57. Published online 2023 Jul 10. doi: 10.1186/s12941-023-00608-9

PMCID:: PMC10334547

Abstract Article PDF–1.8M

Select item 102548067.

Clinical features of Cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome and efficacy of the current therapy

Qing Zhao, Ning-ning Li, You-xin Chen, Xin-yu Zhao

Front Cell Infect Microbiol. 2023; 13: 1107237. Published online 2023 May 26. doi: 10.3389/fcimb.2023.1107237

PMCID:: PMC10254806

Abstract Article PDF–6.2M

Select item 27286028.

Epidemiology of non-keratinocytic skin cancers among persons with acquired immunodeficiency syndrome in the U.S.

Emilie Lanoy, Graça M. Dores, Margaret M. Madeleine, Jorge R. Toro, Joseph F. Fraumeni, Jr., Eric A. Engels

AIDS. Author manuscript; available in PMC 2010 Jan 28.

Published in final edited form as: AIDS. 2009 Jan 28; 23(3): 385–393. doi: 10.1097/QAD.0b013e3283213046

PMCID:: PMC2728602

Abstract Article PDF–593K

Select item 107312469.

Combining CD4 count, CD8 count and CD4/CD8 ratio to predict risk of mortality among HIV-positive adults after therapy: a group-based multi-trajectory analysis

Jing Ma, Guoyong Wang, Xiaoyan Zhu, Ling Li, Lin Wang, Lianzheng Hao, Lijie Gao, Wei Ma, Na Zhang

Front Immunol. 2023; 14: 1269650. Published online 2023 Dec 6. doi: 10.3389/fimmu.2023.1269650

PMCID:: PMC10731246

Abstract Article PDF–1.2M

Select item 837604510.

Nationwide surveillance of AIDS-defining illnesses among HIV patients in Japan from 1995 to 2017

Takeshi Tanaka, Kazuhiro Oshima, Kei Kawano, Masato Tashiro, Akitaka Tanaka, Ayumi Fujita, Misuzu Tsukamoto, Akira Yasuoka, Katsuji Teruya, Koichi Izumikawa

PLoS One. 2021; 16(8): e0256452. Published online 2021 Aug 19. doi: 10.1371/journal.pone.0256452

PMCID:: PMC8376045

Abstract Article PDF–1.2M

Select item 849170311.

Effect of antiretroviral therapy initiation time and baseline CD4⁺ cell counts on AIDS-related mortality among former plasma donors in China: a 21-year retrospective cohort study

Yongli Yang, Yang Li, Xuening Zhang, Weiping Zhang, Yanmin Ma, Xiaocan Jia, Theodore Gondwe, Yuping Wang, Xuezhong Shi

Glob Health Action. 2021; 14(1): 1963527. Published online 2021 Oct 1. doi: 10.1080/16549716.2021.1963527

PMCID:: PMC8491703

Abstract Article PDF–1.1M

Select item 415688612.

Evaluating Protocol Lifecycle Time Intervals in HIV/AIDS Clinical Trials

Scott R. Rosas, Jeffrey T. Schouten, Dennis Dixon, Suresh Varghese, Marie T. Cope, Joe Marci, Jonathan M. Kagan

Clin Trials. Author manuscript; available in PMC 2015 Oct 1.

Published in final edited form as: Clin Trials. 2014 Oct; 11(5): 553–559. Published online 2014 Jun 30. doi: 10.1177/1740774514540814

PMCID:: PMC4156886

Abstract Article PDF–198K

Select item 419516213.

Medicaid home and community-based waivers for acquired immunodeficiency syndrome patients

Phoebe A. Lindsey, Peter D. Jacobson, Anthony H. Pascal

Health Care Financ Rev. 1990 Dec; 1990(Suppl): 109–118.

PMCID:: PMC4195162

Abstract Article PDF–916K

Select item 30390414.

Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion.

J Laurence, S M Friedman, E K Chartash, M K Crow, D N Posnett

J Clin Invest. 1989 Jun; 83(6): 1843–1848. doi: 10.1172/JCI114090

PMCID:: PMC303904

Summary Page Browse PDF–1.1M

Select item 452086715.

Ocular Manifestations of Acquired Immunodeficiency Syndrome

Young Shin Kim, Hae Jung Sun, Tae Hyong Kim, Kui Dong Kang, Sung Jin Lee

Korean J Ophthalmol. 2015 Aug; 29(4): 241–248. Published online 2015 Jul 21. doi: 10.3341/kjo.2015.29.4.241

PMCID:: PMC4520867

Abstract Article PDF–21M

Select item 1094461516.

Effectiveness of human immunodeficiency virus prevention strategies by mapping the geographic dispersion pattern of human immunodeficiency virus prevalence in Nanning, China

Ping Cen, Guo Xu, Jianxun Wu, Jiao Qin, Jinfeng He, Xiaofang Deng, Xi Yang, Peng Lu, Mengni Nong, Junjun Jiang, Li Ye, Hongyang Tang, Bingyu Liang, Hao Liang

BMC Public Health. 2024; 24: 831. Published online 2024 Mar 16. doi: 10.1186/s12889-024-18345-9

PMCID:: PMC10944615

Abstract Article PDF–15M

Select item 951723017.

Mortality and Causes of Death among Individuals Diagnosed with Human Immunodeficiency Virus in Korea, 2004–2018: An Analysis of a Nationwide Population-Based Claims Database

Boyoung Park, Yunsu Choi, Jung Ho Kim, Hye Seong, Youn Jeong Kim, Myungsun Lee, Jaehyun Seong, Shin-Woo Kim, Joon Young Song, Hee-Jung Choi, Dae Won Park, Hyo Youl Kim, Jun Yong Choi, Sang Il Kim, Bo-Youl Choi

Int J Environ Res Public Health. 2022 Sep; 19(18): 11788. Published online 2022 Sep 18. doi: 10.3390/ijerph191811788

PMCID:: PMC9517230

Abstract Article PDF–670K

Select item 620682118.

Prevalence of arterial hypertension and risk factors among people with acquired immunodeficiency syndrome

Gilmara Holanda da Cunha, Maria Amanda Correia Lima, Marli Teresinha Gimeniz Galvão, Francisco Vagnaldo Fechine, Marina Soares Monteiro Fontenele, Larissa Rodrigues Siqueira

Rev Lat Am Enfermagem. 2018; 26: e3066. Published online 2018 Oct 25. doi: 10.1590/1518-8345.2684.3066

PMCID:: PMC6206821

Abstract Article PDF–862K

Select item 396534919.

The Risk of Hepatocellular Carcinoma Among Individuals With Acquired Immunodeficiency Syndrome in the United States

Vikrant V. Sahasrabuddhe, Meredith S. Shiels, Katherine A. McGlynn, Eric A. Engels

Cancer. Author manuscript; available in PMC 2014 Mar 25.

Published in final edited form as: Cancer. 2012 Dec 15; 118(24): 6226–6233. Published online 2012 Jun 26. doi: 10.1002/cncr.27694

PMCID:: PMC3965349

Abstract Article PDF–421K

Select item 717229620.

Prevalence of acute enteric viral pathogens in acquired immunodeficiency syndrome patients with diarrhea

Kaarel T. Kaljot, Jing Ping Ling, Jonathan W.M. Gold, Barbara E. Laughon, John G. Bartlett, Donald P. Kotler, Lyndon S. Oshiro, Harry B. Greenberg

Gastroenterology. 1989 Oct; 97(4): 1031–1032. Published online 2016 Jun 10. doi: 10.1016/0016-5085(89)91516-3

PMCID:: PMC7172296

Abstract Article PDF–334K

<< First< Prev

Page of 27416

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for AIDS

Figure 2

Risk of invasive human papillomavirus (HPV)–associated cancers among persons with AIDS, according to time relative to AIDS onset. Standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for invasive HPV-associated cancers are presented across the following five risk periods relative to AIDS onset: a = 60–25 months before AIDS; b = 24–7 months before AIDS; c = 6 months before to 3 months after AIDS (the AIDS onset period); d = 4–27 months after AIDS; and e = 28–60 months after AIDS. The AIDS onset period was excluded from trend analyses. P_trend values were calculated by use of Poisson regression. All statistical tests were two-sided.

Risk of Human Papillomavirus–Associated Cancers Among Persons With AIDS

J Natl Cancer Inst. 2009 Aug 19;101(16):1120-1130.
Figure 1

Risk of in situ human papillomavirus (HPV)–associated cancers among persons with AIDS, according to time relative to AIDS onset. Standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for in situ HPV-associated cancers are presented across the following five risk periods relative to AIDS onset: a = 60–25 months before AIDS; b = 24–7 months before AIDS; c = 6 months before to 3 months after AIDS (the AIDS onset period); d = 4–27 months after AIDS; and e = 28–60 months after AIDS. The AIDS onset period was excluded from trend analyses. P_trend values were calculated by use of Poisson regression. All statistical tests were two-sided.

Risk of Human Papillomavirus–Associated Cancers Among Persons With AIDS

J Natl Cancer Inst. 2009 Aug 19;101(16):1120-1130.
Figure 3Proportion of AIDS diagnoses by age group, by year—Canada, 2007–2016

Note: Quebec AIDS data have not been available since June 30, 2003. British Columbia AIDS data were not available for 2016. AIDS is no longer a reportable disease in Newfoundland and Labrador as of 2009 and in Prince Edward Island as of 2012. This also excludes AIDS cases for which age was not reported

AIDS in Canada—Surveillance Report, 2016

Can Commun Dis Rep. 2017 Dec 7;43(12):257-261.
Figure 4Number of reported AIDS diagnoses by sex—Canada, 2007–2016

Note: Quebec AIDS data have not been available since June 30, 2003. British Columbia AIDS data were not available for 2016. AIDS is no longer a reportable disease in Newfoundland and Labrador as of 2009 and in Prince Edward Island as of 2012. This also excludes AIDS cases for which sex was not reported or was reported as transsexual or transgender

AIDS in Canada—Surveillance Report, 2016

Can Commun Dis Rep. 2017 Dec 7;43(12):257-261.